← Back to headlines
Lumexa Outlines $235M-$241M Adjusted EBITDA for 2026
Lumexa has projected an adjusted EBITDA between $235 million and $241 million for 2026, driven by the expansion of its joint venture with the Hospital for Special Surgery.
13 Aug, 06:38 — 13 Aug, 06:38
Sources
Showing 1 of 1 sources
